Biology of the cardiac myocyte in heart disease

Molecular Biology of the Cell

Volumn 27, Issue 14, 2016, Pages 2149-2160

  Peter, Angela K ^a   Bjerke, Maureen A ^a   Leinwand, Leslie A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; DISEASE COURSE; ENGINEERED HEART TISSUE; HEART DISEASE; HEART FUNCTION; HUMAN; HUMAN EMBRYONIC STEM CELL; INDUCED PLURIPOTENT STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ANIMAL; CARDIAC MUSCLE; CARDIOMEGALY; HEART FAILURE; METABOLISM; PATHOLOGY;

ANIMALS; CARDIOMEGALY; HEART DISEASES; HEART FAILURE; HUMANS; MYOCARDIUM; MYOCYTES, CARDIAC;

EID: 84978737257     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E16-01-0038     Document Type: Review

References (149)

1. Abi-Gerges N, Pointon A, Pullen GF, Morton MJ, Oldman KL, Armstrong D, Valentin JP, Pollard CE (2013). Preservation of cardiomyocytes from the adult heart. J Mol Cell Cardiol 64, 108-119.
2. Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard JC, Chien KR, Caroni P (1997). MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393-403.
3. Astashkina A, Mann B, Grainger DW (2012). A critical evaluation of in vitro cell culture models for high-Throughput drug screening and toxicity. Pharmacol Ther 134, 82-106.
4. Banyasz T, Lozinskiy I, Payne CE, Edelmann S, Norton B, Chen B, Chen-Izu Y, Izu LT, Balke CW (2008). Transformation of adult rat cardiac myocytes in primary culture. Exp Physiol 93, 370-382.
5. Bass GT, Ryall KA, Katikapalli A, Taylor BE, Dang ST, Acton ST, Saucerman JJ (2012). Automated image analysis identifies signaling pathways regulating distinct signatures of cardiac myocyte hypertrophy. J Mol Cell Cardiol 52, 923-930.
6. Bedada FB, Chan SSK, Metzger SK, Zhang L, Zhang J, Garry DJ, Kamp TJ, Kyba M, Metzger JM (2014). Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes. Stem Cell Reports 3, 594-605.
7. Berger HJ, Prasad SK, Davidoff AJ, Pimental D, Ellingsen O, Marsh JD, Smith TW, Kelly RA (1994). Continual electric field stimulation preserves contractile function of adult ventricular myocytes in primary culture. Am J Physiol 266, H341-H349.
8. Bishopric NH, Kedes L (1991). Adrenergic regulation of the skeletal alpha-Actin gene promoter during myocardial cell hypertrophy. Proc Natl Acad Sci USA 88, 2132-2136.
9. Braam SR, Tertoolen L, Casini S, Matsa E, Lu HR, Teisman A, Passier R, Denning C, Gallacher DJ, Towart R, et al. (2013). Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes. Stem Cell Res 10, 48-56.
10. Braam SR, Tertoolen L, van de Stolpe A, Meyer T, Passier R, Mummery CL (2010). Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 4, 107-116.
11. Buvoli M, Buvoli A, Leinwand LA (2012). Effects of pathogenic proline mutations on myosin assembly. J Mol Biol 415, 807-818.
12. Carvajal-Vergara X, Sevilla A, DSouza SL, Ang YS, Schaniel C, Lee DF, Yang L, Kaplan AD, Adler ED, Rozov R, et al. (2010). Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808-812.
13. Chien KR, Knowlton KU, Zhu H, Chien S (1991). Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 5, 3037-3046.
14. Chong JJ, Yang X, Don CW, Minami E, Liu YW, Weyers JJ, Mahoney WM, Van Biber B, Cook SM, Palpant NJ, et al. (2014). Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273-277.
15. Chun YW, Balikov DA, Feaster TK, Williams CH, Sheng CC, Lee J-B, Boire TC, Neely MD, Bellan LM, Ess KC, et al. (2015). Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes. Biomaterials 67, 52-64.
16. Clark WA, Rudnick SJ, LaPres JJ, Andersen LC, LaPointe MC (1993). Regulation of hypertrophy and atrophy in cultured adult heart cells. Circ Res 73, 1163-1176.
17. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ Jr (1998). HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95, 2979-2984.
18. Claycomb WC, Palazzo MC (1980). Culture of the terminally differentiated adult cardiac muscle cell: A light and scanning electron microscope study. Dev Biol 80, 466-482.
19. Communal C, Colucci WS, Singh K (2000). p38 mitogen-Activated protein kinase pathway protects adult rat ventricular myocytes against β-Adrenergic receptor-stimulated apoptosis. Evidence for G(i)-dependent activation. J Biol Chem 275, 19395-19400.
20. Curtis MJ, Macleod BA, Walker MJ (1987). Models for the study of arrhythmias in myocardial ischaemia and infarction: The use of the rat. J Mol Cell Cardiol 19, 399-419.
21. Delcarpio JB, Lanson NA Jr, Field LJ, Claycomb WC (1991). Morphological characterization of cardiomyocytes isolated from a transplantable cardiac tumor derived from transgenic mouse atria (AT-1 cells). Circ Res 69, 1591-1600.
22. Dias P, Desplantez T, El-Harasis MA, Chowdhury RA, Ullrich ND, Cabestrero de Diego A, Peters NS, Severs NJ, MacLeod KT, Dupont E (2014). Characterisation of connexin expression and electrophysiological properties in stable clones of the HL-1 myocyte cell line. PLoS One 9, e90266.
23. Diaz RJ, Wilson GJ (2006). Studying ischemic preconditioning in isolated cardiomyocyte models. Cardiovasc Res 70, 286-296.
24. Discher DE, Mooney DJ, Zandstra PW (2009). Growth factors, matrices, and forces combine and control stem cells. Science 324, 1673-1677.
25. Dolinsky VW, Soltys CL, Rogan KJ, Chan AY, Nagendran J, Wang S, Dyck JR (2015). Resveratrol prevents pathological but not physiological cardiac hypertrophy. J Mol Med 93, 413-425.
26. Drawnel FM, Boccardo S, Prummer M, Delobel F, Graff A, Weber M, Gerard R, Badi L, Kam-Thong T, Bu L, et al. (2014). Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. Cell Rep 9, 810-821.
27. Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, Wang G, Chen J, Ding S (2011). Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol 13, 215-222.
28. Engler AJ, Carag-Krieger C, Johnson CP, Raab M, Tang H-Y, Speicher DW, Sanger JW, Sanger JM, Discher DE (2008). Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J Cell Sci 121, 3794-3802.
29. Fang X, Robinson J, Wang-Hu J, Jiang L, Freeman DA, Rivkees SA, Wendler CC (2015). cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes. Am J Physiol Cell Physiol 309, C425-C436.
30. Feaster TK, Cadar AG, Wang L, Williams CH, Chun YW, Hempel JE, Bloodworth N, Merryman WD, Lim CC, Wu JC, et al. (2015). Matrigel mattress: A method for the generation of single contracting human-induced pluripotent stem cell-derived cardiomyocytes. Circ Res 117, 995-1000.
31. Feest ER, Korte FS, Tu AY, Dai J, Razumova MV, Murry CE, Regnier M (2014). Thin filament incorporation of an engineered cardiac troponin C variant (L48Q) enhances contractility in intact cardiomyocytes from healthy and infarcted hearts. J Mol Cell Cardiol 72, 219-227.
32. Földes G, Mioulane M, Wright JS, Liu AQ, Novak P, Merkely B, Gorelik J, Schneider MD, Ali NN, Harding SE (2011). Modulation of human embryonic stem cell-derived cardiomyocyte growth: A testbed for studying human cardiac hypertrophy? J Mol Cell Cardiol 50, 367-376.
33. Frank D, Kuhn C, Brors B, Hanselmann C, Lödde M, Katus HA, Frey N (2008). Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension 51, 309-318.
34. Fujiwara M, Yan P, Otsuji TG, Narazaki G, Uosaki H, Fukushima H, Kuwahara K, Harada M, Matsuda H, Matsuoka S, et al. (2011). Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A. PLoS One 6, e16734.
35. Geier C, Perrot A, Ozcelik C, Binner P, Counsell D, Hoffmann K, Pilz B, Martiniak Y, Gehmlich K, van der Ven PF, et al. (2003). Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 107, 1390-1395.
36. Gerdes AM, Onodera T, Wang X, McCune SA (1996). Myocyte remodeling during the progression to failure in rats with hypertension. Hypertension 28, 609-614.
37. Hammer K, Ruppenthal S, Viero C, Scholz A, Edelmann L, Kaestner L, Lipp P (2010). Remodelling of Ca2 +handling organelles in adult rat ventricular myocytes during long term culture. J Mol Cell Cardiol 49, 427-437.
38. Han L, Li Y, Tchao J, Kaplan AD, Lin B, Li Y, Mich-Basso J, Lis A, Hassan N, London B, et al. (2014). Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. Cardiovasc Res 104, 258-269.
39. Harary I, Farley B (1963a). In vitro studies on single beating rat heart cells. I. Growth and organization. Exp Cell Res 29, 451-465.
40. Harary I, Farley B (1963b). In vitro studies on single beating rat heart cells. II. Intercellular communication. Exp Cell Res 29, 466-474.
41. Hartman ME, Dai DF, Laflamme MA (2016). Human pluripotent stem cells: prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev 96, 3-17.
42. Harvey PA, Leinwand LA (2011). Cellular mechanisms of cardiomyopathy. J Cell Biol 194, 355-365.
43. Hashem SI, Perry CN, Bauer M, Han S, Clegg SD, Ouyang K, Deacon DC, Spinharney M, Panopoulos AD, Izpisua Belmonte JC, et al. (2015). Brief report: oxidative stress mediates cardiomyocyte apoptosis in a human model of danon disease and heart failure. Stem Cells 33, 2343-2350.
44. Hazeltine LB, Badur MG, Lian X, Das A, Han W, Palecek SP (2014). Temporal impact of substrate mechanics on differentiation of human embryonic stem cells to cardiomyocytes. Acta Biomater 10, 604-612.
45. Heineke J, Wollert KC, Osinska H, Sargent MA, York AJ, Robbins J, Molkentin JD (2010). Calcineurin protects the heart in a murine model of dilated cardiomyopathy. J Mol Cell Cardiol 48, 1080-1087.
46. Holt E, Lunde PK, Sejersted OM, Christensen G (1997). Electrical stimulation of adult rat cardiomyocytes in culture improves contractile properties and is associated with altered calcium handling. Basic Res Cardiol 92, 289-298.
47. Hong HM, Song EJ, Oh E, Kabir MH, Lee C, Yoo YS (2011). Endothelin-1-And isoproterenol-induced differential protein expression and signaling pathway in HL-1 cardiomyocytes. Proteomics 11, 283-297.
48. Horackova M, Croll RP, Hopkins DA, Losier AM, Armour JA (1996). Morphological and immunohistochemical properties of primary long-Term cultures of adult guinea-pig ventricular cardiomyocytes with peripheral cardiac neurons. Tissue Cell 28, 411-425.
49. Huang Q, Huang J, Zeng Z, Luo J, Liu P, Chen S, Liu B, Pan X, Zang L, Zhou S (2015). Effects of ERK1/2/PPARalpha/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine. Life Sci 124, 41-49.
50. Jacobson SL, Piper HM (1986). Cell cultures of adult cardiomyocytes as models of the myocardium. J Mol Cell Cardiol 18, 661-678.
51. Jentzsch C, Leierseder S, Loyer X, Flohrschötz I, Sassi Y, Hartmann D, Thum T, Laggerbauer B, Engelhardt S (2012). A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. J Mol Cell Cardiol 52, 13-20.
52. Jiang X, Xu C, Wang Y, Gao L, Yan C, Li D, Sun H (2012). Beta2-Adrenoceptor transfection enhances contractile reserve of isolated rat ventricular myocytes exposed to chronic isoprenaline stimulation by improving beta1-Adrenoceptor responsiveness. J Recept Signal Transduct Res 32, 36-41.
53. Joshi-Mukherjee R, Dick IE, Liu T, ORourke B, Yue DT, Tung L (2013). Structural and functional plasticity in long-Term cultures of adult ventricular myocytes. J Mol Cell Cardiol 65, 76-87.
54. Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, Chen J, Hattori T, Ohno S, Kita T, Horie M, et al. (2013). Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-Term culture. Circ J 77, 1307-1314.
55. Karakikes I, Senyei GD, Hansen J, Kong CW, Azeloglu EU, Stillitano F, Lieu DK, Wang J, Ren L, Hulot JS, et al. (2014). Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. Stem Cells Transl Med 3, 18-31.
56. Karliner JS, Simpson PC, Taylor JE, Honbo N, Woloszyn W (1985). Adrenergic receptor characteristics of cardiac myocytes cultured in serum-free medium: comparison with serum-supplemented medium. Biochem Biophys Res Commun 128, 376-382.
57. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, Ellis J, Keller G (2011). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8, 228-240.
58. Kehat I, Davis J, Tiburcy M, Accornero F, Saba-el-leil MK, Maillet M, York AJ, Lorenz JN, Zimmermann WH, Meloche S, et al. (2011). ERK1/2 regulate the balance between eccentric and concentric cardiac growth. Circ Res 108, 176-183.
59. Kehat I, Gepstein A, Spira A, Itskovitz-Eldor J, Gepstein L (2002). High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: A novel in vitro model for the study of conduction. Circ Res 91, 659-661.
60. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108, 407-414.
61. Kehat I, Molkentin JD (2010). Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122, 2727-2735.
62. Kimes BW, Brandt BL (1976). Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98, 367-381.
63. Kline RP, Sorota S, Dresdner KP, Steinhelper ME, Lanson NA Jr, Wit AL, Claycomb WC, Field LJ (1993). Spontaneous activity in transgenic mouse heart: comparison of primary atrial tumor with cultured AT-1 atrial myocytes. J Cardiovasc Electrophysiol 4, 642-660.
64. Kono M, Kisanuki A, Takasaki K, Nakashiki K, Yuasa T, Kuwahara E, Mizukami N, Uemura T, Kubota K, Ueya N, et al. (2009). Left ventricular systolic function is abnormal in diastolic heart failure: re-Assessment of systolic function using cardiac time interval analysis. J Cardiol 53, 437-446.
65. Kumai M, Nishii K, Nakamura K, Takeda N, Suzuki M, Shibata Y (2000). Loss of connexin45 causes a cushion defect in early cardiogenesis. Development 127, 3501-3512.
66. Kuo PL, Lee H, Bray MA, Geisse NA, Huang YT, Adams WJ, Sheehy SP, Parker KK (2012). Myocyte shape regulates lateral registry of sarcomeres and contractility. Am J Pathol 181, 2030-2037.
67. Kuznetsov AV, Javadov S, Sickinger S, Frotschnig S, Grimm M (2015). H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation. Biochim Biophys Acta 1853, 276-284.
68. LaMorte VJ, Thorburn J, Absher D, Spiegel A, Brown JH, Chien KR, Feramisco JR, Knowlton KU (1994). Gq-And ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha 1-Adrenergic stimulation. J Biol Chem 269, 13490-13496.
69. Lan F, Lee AS, Liang P, Sanchez-Freire V, Nguyen PK, Wang L, Han L, Yen M, Wang Y, Sun N, et al. (2013). Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12, 101-113.
70. LaNasa SM, Bryant SJ (2009). Influence of ECM proteins and their analogs on cells cultured on 2-D hydrogels for cardiac muscle tissue engineering. Acta Biomater 5, 2929-2938.
71. Lanson NA Jr, Glembotski CC, Steinhelper ME, Field LJ, Claycomb WC (1992). Gene expression and atrial natriuretic factor processing and secretion in cultured AT-1 cardiac myocytes. Circulation 85, 1835-1841.
72. Leychenko A, Konorev E, Jijiwa M, Matter ML (2011). Stretch-Induced hypertrophy activates NFkB-Mediated VEGF secretion in adult cardiomyocytes. PLoS One 6, 1-9.
73. Li AH, Liu PP, Villarreal FJ, Garcia RA (2014). Dynamic changes in myocardial matrix and relevance to disease: Translational perspectives. Circ Res 114, 916-927.
74. Li C, Li J, Cai X, Sun H, Jiao J, Bai T, Zhou XW, Chen X, Gill DL, Tang XD (2011). Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors. J Biol Chem 286, 40782-40791.
75. Liang P, Lan F, Lee AS, Gong T, Sanchez-Freire V, Wang Y, Diecke S, Sallam K, Knowles JW, Wang PJ, et al. (2013). Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 127, 1677-1691.
76. Lindsey SE, Butcher JT, Yalcin HC (2014). Mechanical regulation of cardiac development. Front Physiol 5, 318.
77. Louch WE, Sheehan KA, Wolska BM (2011). Methods in cardiomyocyte isolation, culture, and gene transfer. J Mol Cell Cardiol 51, 288-298.
78. Lu T-Y, Lin B, Kim J, Sullivan M, Tobita K, Salama G, Yang L (2013). Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat Commun 4, 1-11.
79. Lundy SD, Zhu W-Z, Regnier M, Laflamme MA (2013). Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 22, 1991-2002.
80. Ma D, Wei H, Lu J, Huang D, Liu Z, Loh LJ, Islam O, Liew R, Shim W, Cook SA (2015). Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 6, 39.
81. Ma D, Wei H, Zhao Y, Lu J, Li G, Sahib NB, Tan TH, Wong KY, Shim W, Wong P, et al. (2013). Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. Int J Cardiol 168, 5277-5286.
82. Maltsev Va, Kyle JW, Mishra S, Undrovinas A (2008). Molecular identity of the late sodium current in adult dog cardiomyocytes identified by Nav1.5 antisense inhibition. Am J Physiol Heart Circ Physiol 295, H667-H676.
83. Mathur A, Ma Z, Loskill P, Jeeawoody S, Healy KE (2015). In vitro cardiac tissue models: current status and future prospects. Adv Drug Deliv Rev 96, 203-213.
84. Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler J, et al. (2008). Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118, 507-517.
85. McCain ML, Agarwal A, Nesmith HW, Nesmith AP, Parker KK (2014). Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues. Biomaterials 35, 5462-5471.
86. Menaouar A, Florian M, Wang D, Danalache B, Jankowski M, Gutkowska J (2014). Anti-hypertrophic effects of oxytocin in rat ventricular myocytes. Int J Cardiol 175, 38-49.
87. Menard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P (1999). Modulation of L-Type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J Biol Chem 274, 29063-29070.
88. Mtrich M, Lucas A, Gastineau M, Samuel JL, Heymes C, Morel E, Lezoualch F (2008). Epac mediates β-Adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res 102, 959-965.
89. Mitcheson JS, Hancox JC, Levi AJ (1998). Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. Cardiovasc Res 39, 280-300.
90. Miyashita T, Takeishi Y, Takahashi H, Kato S, Kubota I, Tomoike H (2001). Role of calcineurin in insulin-like growth factor-1-induced hypertrophy of cultured adult rat ventricular myocytes. Jpn Circ J 65, 815-819.
91. Mohamed BA, Barakat AZ, Zimmermann WH, Bittner RE, Muhlfeld C, Hunlich M, Engel W, Maier LS, Adham IM (2012). Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis. J Mol Cell Cardiol 53, 459-468.
92. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, Dorn T, Goedel A, Hohnke C, Hofmann F, et al. (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363, 1397-1409.
93. Mu X, Harvey P (2012). Estrogen differentially affects expression of calcium handling genes in female and male adult cardiomyocytes. J Student Res 1, 31-37.
94. Muller M, Stockmann M, Malan D, Wolheim A, Tischendorf M, Linta L, Katz SF, Lin Q, Latz S, Brunner C, et al. (2012). Ca2+ activated K channels-new tools to induce cardiac commitment from pluripotent stem cells in mice and men. Stem Cell Rev 8, 720-740.
95. Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, et al. (2003). Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107, 2733-2740.
96. Mummery C, Ward D, van den Brink CE, Bird SD, Doevendans PA, Opthof T, Brutel de la Riviere A, Tertoolen L, van der Heyden M, Pera M (2002). Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat 200, 233-242.
97. Murata M, Tohyama S, Fukuda K (2010). Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery. Pharmacol Ther 126, 109-118.
98. Nakaoka M, Iwai-Kanai E, Katamura M, Okawa Y, Mita Y, Matoba S (2015). An alpha-Adrenergic agonist protects hearts by inducing Akt1-mediated autophagy. Biochem Biophys Res Commun 456, 250-256.
99. Naqvi N, Li M, Yahiro E, Graham RM, Husain A (2009). Insights into the characteristics of mammalian cardiomyocyte terminal differentiation shown through the study of mice with a dysfunctional c-kit. Pediatr Cardiol 30, 651-658.
100. Niebruegge S, Nehring A, Bar H, Schroeder M, Zweigerdt R, Lehmann J (2008). Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Eng Part A 14, 1591-1601.
101. Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, Xiao Y, Zhang B, Jiang J, Massé S, Gagliardi M, Hsieh A, et al. (2013). Biowire: A platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 10, 781-787.
102. OConnell TD, Rodrigo MC, Simpson PC (2007). Isolation and culture of adult mouse cardiac myocytes. Cardiovasc. Proteomics 357, 271-296.
103. Olsson MC, Palmer BM, Stauffer BL, Leinwand LA, Moore RL (2004). Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Circ Res 94, 201-207.
104. Ott HC, Matthiesen TS, Goh S-K, Black LD, Kren SM, Netoff TI, Taylor Da (2008). Perfusion-decellularized matrix: using natures platform to engineer a bioartificial heart. Nat Med 14, 213-221.
105. Ou DB, He Y, Chen R, Teng JW, Wang HT, Zeng D, Liu XT, Ding L, Huang JY, Zheng QS (2011). Three-dimensional co-culture facilitates the differentiation of embryonic stem cells into mature cardiomyocytes. J Cell Biochem 112, 3555-3562.
106. Paige SL, Osugi T, Afanasiev OK, Pabon L, Reinecke H, Murry CE (2010). Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One 5, e11134.
107. Pioner JM, Racca AW, Klaiman JM, Yang K-C, Guan X, Pabon L, Muskheli V, Zaunbrecher R, Macadangdang J, Jeong MY, et al. (2016). Isolation and mechanical measurements of myofibrils from human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports 6, 885-896.
108. Powell T, Twist VW (1976). A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. Biochem Biophys Res Commun 72, 327-333.
109. Reid BG, Stratton MS, Bowers S, Cavasin MA, Demos-Davies KM, McKinsey TA (2016). Discovery of novel small molecule inhibitors of cardiac hypertrophy using high throughput, high content imaging. J Mol Cell Cardiol 97, 106-113.
110. Ribeiro AJS, Ang Y-S, Fu J-D, Rivas RN, Mohamed TMA, Higgs GC, Srivastava D, Pruitt BL (2015). Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness. Proc Natl Acad Sci USA 112, 12705-12710.
111. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR (1991). Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88, 8277-8281.
112. Ryall KA, Bezzerides VJ, Rosenzweig A, Saucerman JJ (2014). Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation. J Mol Cell Cardiol 72, 74-84.
113. Shapira-Schweitzer K, Habib M, Gepstein L, Seliktar D (2009). A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. J Mol Cell Cardiol 46, 213-224.
114. Shenasa M, Shenasa H, El-Sherif N (2015). Left ventricular hypertrophy and arrhythmogenesis. Card Electrophysiol Clin 7, 207-220.
115. Simpson P (1983). Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response. J Clin Invest 72, 732-738.
116. Simpson P, McGrath A, Savion S (1982). Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 51, 787-801.
117. Snabaitis AK, Muntendorf A, Wieland T, Avkiran M (2005). Regulation of the extracellular signal-regulated kinase pathway in adult myocardium: differential roles of Gq/11, Gi and G 12/13 proteins in signalling by α1-Adrenergic, endothelin-1 and thrombin-sensitive protease-Activated receptors. Cell Signal 17, 655-664.
118. Snir M, Kehat I, Gepstein A, Coleman R, Itskovitz-Eldor J, Livne E, Gepstein L (2003). Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285, H2355-H2363.
119. Sowah D, Brown BF, Quon A, Alvarez BV, Casey JR (2014). Resistance to cardiomyocyte hypertrophy in ae3-/-mice, deficient in the AE3 Cl-/HCO3-exchanger. BMC Cardiovasc Disord 14, 89.
120. Steinhelper ME, Lanson NA, Dresdner KP, Delcarpio JB, Wit AL, Claycomb WC, Field LJ (1990). Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice. Am J Physiol 259, H1826-H1834.
121. Takahashi K, Yamanaka S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
122. Takasaki K, Miyata M, Imamura M, Yuasa T, Kuwahara E, Kubota K, Kono M, Ueya N, Horizoe Y, Chaen H, et al. (2012). Left ventricular dysfunction assessed by cardiac time interval analysis among different geometric patterns in untreated hypertension. Circ J 76, 1409-1414.
123. Thandapilly SJ, Louis XL, Yang T, Stringer DM, Yu L, Zhang S, Wigle J, Kardami E, Zahradka P, Taylor C, et al. (2011). Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway. Eur J Pharmacol 668, 217-224.
124. Thavandiran N, Dubois N, Mikryukov A, Massé S, Beca B, Simmons CA, Deshpande VS, McGarry JP, Chen CS, Nanthakumar K, et al. (2013). Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc Natl Acad Sci USA 110, E4698-E4707.
125. Thompson BR, Metzger JM (2014). Cell biology of sacromeric protein engineering: disease modeling and therapeutic potential. Anat Rec 297, 1663-1669.
126. Tian Q, Pahlavan S, Oleinikow K, Jung J, Ruppenthal S, Scholz A, Schumann C, Kraegeloh A, Oberhofer M, Lipp P, et al. (2012). Functional and morphological preservation of adult ventricular myocytes in culture by sub-micromolar cytochalasin D supplement. J Mol Cell Cardiol 52, 113-124.
127. Tiburcy M, Didié M, Boy O, Christalla P, Döker S, Naito H, Karikkineth BC, El-Armouche A, Grimm M, Nose M, et al. (2011). Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circ Res 109, 1105-1114.
128. Tiburcy M, Zimmermann WH (2014). Modeling myocardial growth and hypertrophy in engineered heart muscle. Trends Cardiovasc Med 24, 7-13.
129. Tsai CT, Chiang FT, Chen WP, Hwang JJ, Tseng CD, Wu CK, Yu CC, Wang YC, Lai LP, Lin JL (2011). Angiotensin II induces complex fractionated electrogram in a cultured atrial myocyte monolayer mediated by calcium and sodium-calcium exchanger. Cell Calcium 49, 1-11.
130. Tulloch NL, Muskheli V, Razumova MV, Korte FS, Regnier M, Hauch KD, Pabon L, Reinecke H, Murry CE (2011). Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 109, 47-59.
131. Turnbull IC, Karakikes I, Serrao GW, Backeris P, Lee JJ, Xie C, Senyei G, Gordon RE, Li RA, Akar FG, et al. (2014). Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J 28, 644-654.
132. Tzatzalos E, Abilez OJ, Shukla P, Wu JC (2016). Engineered heart tissues and induced pluripotent stem cells: macro-And microstructures for disease modeling, drug screening, and translational studies. Adv Drug Deliv Rev 96, 234-244.
133. von Lueder TG, Wang BH, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H (2015). Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. Circ Heart Fail 8, 71-78.
134. Waring CD, Vicinanza C, Papalamprou A, Smith AJ, Purushothaman S, Goldspink DF, Nadal-Ginard B, Torella D, Ellison GM (2014). The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation. Eur Heart J 35, 2722-2731.
135. Watkins SJ, Borthwick GM, Arthur HM (2011). The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim 47, 125-131.
136. White SM, Constantin PE, Claycomb WC (2004). Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 286, H823-H829.
137. Wijnker PJM, Friedrich FW, Dutsch A, Reischmann S, Eder A, Vollert-Mannhardt I, Mearini G, Eschenhagen T, van der Velden J, Carrier L (2016). Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue. J Mol Cell Cardiol 97, 82-92.
138. Yahalom-Ronen Y, Rajchman D, Sarig R, Geiger B, Tzahor E (2015). Reduced matrix rigidity promotes neonatal cardiomyocyte dedifferentiation, proliferation and clonal expansion. Elife 4, 1-18.
139. Yang T, Wathen MS, Felipe A, Tamkun MM, Snyders DJ, Roden DM (1994). K+ currents and K+ channel mRNA in cultured atrial cardiac myocytes (AT-1 cells). Circ Res 75, 870-878.
140. Yang X, Pabon L, Murry CE (2014). Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 114, 511-523.
141. Young JL, Engler AJ (2011). Hydrogels with time-dependent material properties enhance cardiomyocyte differentiation in vitro. Biomaterials 32, 1002-1009.
142. Zanella F, Lyon RC, Sheikh F (2014). Modeling heart disease in a dish: from somatic cells to disease-relevant cardiomyocytes. Trends Cardiovasc Med 24, 32-44.
143. Zanella F, Sheikh F (2016). Patient-specific induced pluripotent stem cell models: generation and characterization of cardiac cells. Methods Mol Biol 1353, 147-162.
144. Zhang B, Montgomery M, Chamberlain MD, Ogawa S, Korolj A, Pahnke A, Wells LA, Massé S, Kim J, Reis L, et al. (2016). Biodegradable scaffold with built-in vasculature for organ-on-A-chip engineering and direct surgical anastomosis. Nat Mater 15, 669-678.
145. Zhang JH, Chung TD, Oldenburg KR (1999). A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4, 67-73.
146. Zhang Q, Jiang J, Han P, Yuan Q, Zhang J, Zhang X, Xu Y, Cao H, Meng Q, Chen L, et al. (2011). Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res 21, 579-587.
147. Zhou Y-Y, Wang S-Q, Zhu W-Z, Chruscinski A, Kobilka BK, Ziman B, Wang S, Lakatta EG, Cheng H, Xiao R-P (2000). Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am J Physiol Heart Circ Physiol 279, H429-H436.
148. Zhu R, Blazeski A, Poon E, Costa KD, Tung L, Boheler KR (2014). Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 5, 117.
149. Zobel C, Kassiri Z, Nguyen TT, Meng Y, Backx PH (2002). Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes. Circulation 106, 2385-2391.